Herbert Conrad

Herbert J.
Conrad was the founder of Matinas BioPharma Holdings, Inc., founded in 2013, where the title held was Independent Director from 2022 to 2025.
Mr. Conrad is also the founder of Reliant Pharmaceuticals LLC.
Mr. Conrad is currently an Independent Director at Celldex Therapeutics, Inc., a position held since 2008.
Former positions include Chairman at Bone Care International, Inc.; Chairman at GenVec, Inc. from 1996 to 2003; Chairman at Sapphire Therapeutics, Inc. from 2005 to 2009; Chairman at Matinas BioPharma, Inc. from 2012 to 2022; Director at Savient Pharmaceuticals, Inc.; Director at Dura Pharmaceuticals, Inc.; Director at UroCor, Inc.; Director at AVANT Immunotherapeutics, Inc. in 2008; Director at SICOR, Inc.; President & Director at Roche Pharmaceuticals, Inc. from 1982 to 1993; Director at Pharmasset, Inc. from 2008 to 2011; Independent Director at Arbutus Biopharma Corp.; Director at Symphony Evolution, Inc. from 2005 to 2009; Director at Gensia Sicor Pharmaceuticals, Inc.; Director at Celldex Research Corp.; and President-US Pharmaceuticals Division at F.
Hoffmann-La Roche Ltd. from 1982 to 1993.
Education includes undergraduate and graduate degrees from Arnold & Marie Schwartz College of Pharmacy & Health Science.